Dexmedetomidine was approved by the Food and Drug Administration at the end of 1999 for use in humans as a short-term medication (<24 hours) for analgesia and sedation in the intensive care unit (ICU). Its unique properties render it suitable for sedation and analgesia during the whole perioperative period.
« Back to Glossary IndexOverdose Word of the Week
Drug Diversion
Drug diversion is a medical and legal concept involving the illegal movement, adulteration, marketing, or transfer of any legal controlled substance anywhere within the supply chain; from manufacturer to end user.
